Wed, November 15, 2023

Hartaj Singh Maintained (ATXS) at Buy with Decreased Target to $25 on, Nov 15th, 2023

Hartaj Singh of Oppenheimer, Maintained "Astria Therapeutics, Inc." (ATXS) at Buy with Decreased Target from $30 to $25 on, Nov 15th, 2023.

Hartaj has made no other calls on ATXS in the last 4 months.



There are 2 other peers that have a rating on ATXS. Out of the 2 peers that are also analyzing ATXS, 0 agree with Hartaj's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Hartaj


  • Laura Chico of "Wedbush" Maintained at Buy with Decreased Target to $18 on, Friday, October 13th, 2023
  • Joseph Pantginis of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $18 on, Thursday, October 12th, 2023